Related Experiment Videos
Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors
A Krautheim1, P Brechlin, K Becker
1Institute of Pharmacology and Toxicology, University of Gottingen, D-37075 Gottingen, Germany.
Abstract:
Specific inhibitors of serine/threonine phosphatases like okadaic acid can induce apoptotic cell death in the pancreatic beta cell line HIT. Cultivation in stepwise increased concentrations of okadaic acid enabled the isolation of HIT100R cells which proliferate at 100 nM okadaic acid (8 - 10 times the initially lethal concentration). These two cell lines were used to characterize the events triggered by okadaic acid that led to apoptosis. Biochemical markers, e.g. cytochrome c release from mitochondria and increase of caspase-3-like activity, revealed that induction of apoptosis by 100 nM okadaic acid in parental HIT cells started with the release of cytochrome c. In HIT100R cells 500 nM okadaic acid were necessary to induce alterations comparable to those observed with 100 nM okadaic acid in non-resistant HIT cells. In contrast to okadaic acid, the potency of the structurally different phosphatase inhibitor cantharidic acid to induce cytochrome c release, increase of caspase-3-like activity and DNA fragmentation was comparable in HIT and HIT100R cells. Thus, no cross-resistance between these phosphatase inhibitors seemed to exist. Phosphatase activity in extracts from HIT and HIT100R cells did not differ in its total amount or in its sensitivity for okadaic acid. Since higher concentrations of okadaic acid were needed to induce apoptosis in HIT100R cells, a compromised intracellular accumulation of the toxin appeared likely. Functional and structural analysis revealed that this was achieved by the development of the multidrug resistance phenotype in HIT100R cells. The underlying mechanism appeared to be the enhanced expression of the pgp1 but not the pgp2 gene.
Insights
Pancreatic beta cells resistant to okadaic acid developed multidrug resistance, likely due to enhanced pgp1 gene expression. This resistance did not extend to other phosphatase inhibitors like cantharidic acid.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Okadaic acid, a serine/threonine phosphatase inhibitor, induces apoptotic cell death in pancreatic beta cells.
- Development of resistance to okadaic acid in HIT cells (HIT100R) allows proliferation at previously lethal concentrations.
Purpose of the Study:
- To characterize the apoptotic events triggered by okadaic acid in parental HIT and resistant HIT100R cells.
- To investigate the mechanism of resistance to okadaic acid and potential cross-resistance with other phosphatase inhibitors.
Main Methods:
- Induction of apoptosis using okadaic acid and cantharidic acid.
- Biochemical analysis of apoptosis markers (cytochrome c release, caspase-3 activity).
- Assessment of phosphatase activity and drug accumulation.
- Analysis of multidrug resistance gene expression (pgp1, pgp2).
Main Results:
- Apoptosis induction by okadaic acid required higher concentrations in HIT100R cells compared to HIT cells.
- No cross-resistance was observed with cantharidic acid, indicating distinct resistance mechanisms.
- HIT100R cells exhibited the multidrug resistance phenotype, linked to enhanced pgp1 gene expression.
- Total phosphatase activity and sensitivity to okadaic acid were similar in both cell lines.
Conclusions:
- HIT100R cells acquired resistance to okadaic acid through the development of multidrug resistance, specifically involving pgp1.
- The resistance mechanism is specific to okadaic acid and does not confer cross-resistance to structurally different phosphatase inhibitors.
- Understanding these resistance mechanisms is crucial for developing targeted therapies for pancreatic beta cell protection or drug development.